73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Mechanism of a breast cancer drug points to a possible new therapy

Mechanism of a breast cancer drug points to a possible new therapy

by Sarah Avery,Duke UniversityThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom

Mechanism of a breast cancer drug points to a possible new therapy

by Sarah Avery,Duke UniversityThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom
Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouragin

Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouragin
Study reveals persistent cancer disparities in Appalachian Kentucky

Study reveals persistent cancer disparities in Appalachian Kentucky

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA recent University of Kentucky Markey Cancer Center study published inThe Journal of Rural Healthsheds lig

Study reveals persistent cancer disparities in Appalachian Kentucky

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA recent University of Kentucky Markey Cancer Center study published inThe Journal of Rural Healthsheds lig
Health insurance premiums dropped? Not so fast

Health insurance premiums dropped? Not so fast

by E.J. Antoni, The Heritage FoundationCredit: Pixabay/CC0 Public DomainThe latest Consumer Price Index report showed inflation slowing in October, due in part to a supposed 34% drop in the cost of he

Health insurance premiums dropped? Not so fast

by E.J. Antoni, The Heritage FoundationCredit: Pixabay/CC0 Public DomainThe latest Consumer Price Index report showed inflation slowing in October, due in part to a supposed 34% drop in the cost of he
Vaccine boosts response of engineered T cells, may help eradicate solid tumors

Vaccine boosts response of engineered T cells, may help eradicate solid tumors

by Massachusetts Institute of TechnologyCredit: CC0 Public DomainEngineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. How

Vaccine boosts response of engineered T cells, may help eradicate solid tumors

by Massachusetts Institute of TechnologyCredit: CC0 Public DomainEngineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. How
Age, cancer type affect COVID-19 vaccine uptake in cancer patients

Age, cancer type affect COVID-19 vaccine uptake in cancer patients

by Elana GotkineFor patients with cancer, age, cancer type, and comorbidity are associated with differential COVID-19 vaccine uptake rates, according to a study published online March 15 inCance

Age, cancer type affect COVID-19 vaccine uptake in cancer patients

by Elana GotkineFor patients with cancer, age, cancer type, and comorbidity are associated with differential COVID-19 vaccine uptake rates, according to a study published online March 15 inCance
New review on p53 biology and reactivation in blood cancers

New review on p53 biology and reactivation in blood cancers

byKarolinska InstitutetA simplified scheme of p53 regulation in cells upon stress and the drugs currently evaluated in clinical trials for p53 reactivation for improved therapy in MDS and AML. C

New review on p53 biology and reactivation in blood cancers

byKarolinska InstitutetA simplified scheme of p53 regulation in cells upon stress and the drugs currently evaluated in clinical trials for p53 reactivation for improved therapy in MDS and AML. C
Deep learning algorithm may streamline lung cancer radiotherapy treatment

Deep learning algorithm may streamline lung cancer radiotherapy treatment

byBrigham and Women's HospitalCredit: Unsplash/CC0 Public DomainLung cancer, the most common cancer worldwide, is targeted with radiation therapy (RT) in nearly one-half of cases. RT plannin

Deep learning algorithm may streamline lung cancer radiotherapy treatment

byBrigham and Women's HospitalCredit: Unsplash/CC0 Public DomainLung cancer, the most common cancer worldwide, is targeted with radiation therapy (RT) in nearly one-half of cases. RT plannin
Study reveals lower predictive ability for renal cancer models

Study reveals lower predictive ability for renal cancer models

(HealthDay)—Prospective validation of existing renal cell carcinoma (RCC) prediction models demonstrates a decrease in their predictive ability, according to a study published online June 19 in the&nb

Study reveals lower predictive ability for renal cancer models

(HealthDay)—Prospective validation of existing renal cell carcinoma (RCC) prediction models demonstrates a decrease in their predictive ability, according to a study published online June 19 in the&nb
Tumor resistance is promoted by anti-cancer protein

Tumor resistance is promoted by anti-cancer protein

by Champalimaud Centre for the UnknownCredit: CC0 Public DomainLack of oxygen, or hypoxia, is a biological stressor that occurs under various conditions such as wound healing and stroke. To rescue the

Tumor resistance is promoted by anti-cancer protein

by Champalimaud Centre for the UnknownCredit: CC0 Public DomainLack of oxygen, or hypoxia, is a biological stressor that occurs under various conditions such as wound healing and stroke. To rescue the
Elegant antibody nanoparticles override immunological tolerance of tumors

Elegant antibody nanoparticles override immunological tolerance of tumors

by Chinese Academy of SciencesSchematic illustration of the engineered antibody nanoparticle for robust cancer immunotherapy. Credit: WANG DanggeImmune checkpoint blockade (ICB) therapy using the

Elegant antibody nanoparticles override immunological tolerance of tumors

by Chinese Academy of SciencesSchematic illustration of the engineered antibody nanoparticle for robust cancer immunotherapy. Credit: WANG DanggeImmune checkpoint blockade (ICB) therapy using the
New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

byWolters Kluwer HealthPositive biopsy-free survival with 95% confidence limits (shaded gray areas). Credit:Journal of Urology(2023). DOI: 10.1097/JU.0000000000003038For men with ear

New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

byWolters Kluwer HealthPositive biopsy-free survival with 95% confidence limits (shaded gray areas). Credit:Journal of Urology(2023). DOI: 10.1097/JU.0000000000003038For men with ear